HBOT Conversations:
Elena Schertz & Tom Fox (Part 2) – Concussion

 

Elena Schertz, NP and Tom Fox of Extivita-RTP in Raleigh, NC join us in a 5-part series to discuss the extraordinary healing they’ve witnessed through the God-given natural therapy of HBOT. This is Part 2, with a focus on how Hyperbaric Oxygen Therapy is helping people of all ages heal from concussions.

Elena Schetz, NP is the nurse practitioner, and Tom Fox is the Safety Director at Extivita-RTP. Extivita-RTP offers a positive environment for healing, and they encourage anyone seeking a better quality of life to come visit them and experience for themselves the wonder of Hyperbaric Oxygen Therapy.

Subscribe. Join the discussion. Share the hope.

Watch the Podcast

In a Special 5-part series with Extivita’s Nurse Practitioner, Elena Schertz, and Safety Director, Tom Fox, we dive into the extraordinary powers of HBOT, and the healing they have witnessed for a variety of conditions. Part 1 was released on 3/17/2023 with a focus on PTSD for veterans.

In Part 2 of 5, we discuss concussions, and the importance of treating concussions with Hyperbarics within days of the injury. 

Host di Girolamo starts the conversation talking about the adolescent group in Wake County, North Carolina and stating that it’s his understanding there are approximately 3,000 adolescent concussions from sport injuries in this county alone (the country HBOT News studio and the clinic, Extivita-RTP is located at).  This opens a door to discuss concussions and how critical it is to treat a head injury in the acute (very early) stage.

It’s a classic prognosis we’ve all heard regarding healing from concussions, ‘Rest your brain. Time will heal’. 

Tom Fox explains, “Time also makes things worse”. 

He uses a defensive back, Shazier, as an example. Shazier was injured and had a neurological injury with a contusion to the spinal cord. His prognosis was not good, and he was expected to become a quadriplegic.  What’s critical in a case like this is the implementation of hyperbarics in a timely fashion, before any swelling can cause a scar to form.; as this can be the difference between whether the patient will be able to walk again, or if he/she is going to spend the rest of their days in a wheelchair.  Shazier played for the Pittsburgh Steelers, and was under the care of Dr. Joseph Maroon (who was portrayed as a character in the movie, Concussion). Thanks to Dr. Maroon’s passion to treat with HBOT, Shazier received HBOT quickly, and is walking today! It’s a fascinating story of healing!

Since hypoxia and inflammation are the root cause of injury and illness, Fox expresses that it’s beyond time the medical community works together and starts asking the question, ‘Hey, which one of your patients would benefit from use of oxygen to relieve hypoxia and inflammation?’. Fox also mentions that concussions and strokes are similar in the way that they need to be treated with Hyperbaric Oxygen Therapy immediately before brain damage can be done.

It’s only evolving if you let it evolve, but if you actually have a timely implementation of therapeutic hyperbarics, then it may not be evolving. It may be stopped in its tracks. We as a community need to be better at communicating with the mainstream medicine and saying, ‘Hey, listen, we have a therapy that can make the difference in your patient’. You know, it’s not an alternative. It’s actually the drugs that are the alternative. So let’s try to reestablish and take care of the hypoxia that’s causing the injury.

Elena stresses that she’s seen many concussions in the clinic, and that if they can treat with HBOT preferably within 24 hours (although that’s not realistic many times), but at least within the acute phase, which is 72 hours, then it’s only two or three hyperbaric dives that the patient needs in order to return back to their baseline.  In addition, she reiterates that even if the patient is in a subacute or chronic stage of concussion there’s still hope.

I also want to emphasize that even if it’s ten weeks out or a year out or ten years out, we’ve also seen benefits in those folks. But if we get them right away, it can bring them right back to baseline immediately. Like within three dives, like I said, 3 to 5, and I’ve seen that.

The number of treatments a patient would typically need is discussed, with Tom and Elena stressing that a 40 dives is excessive for concussions in the acute stage — even multiple concussions. Other factors come into play with a 40 dive protocol, including comorbidities.  Tom Fox makes an excellent point in regards to the 40 dive treatment protocol that so many medical providers think is needed for a patient to complete HBOT dives and heal. 

The thing with hyperbarics is it’s gotten a bad rap for extended protocols like 40 treatments. 60 treatments. Who can do that? Who can afford to do that? You know, why doesn’t insurance companies reimburse for this? Because usually it’s an extended course of therapy that requires an extraordinary amount of money. And that’s one of the chief things that holds us back.

Treat early and you will often eliminate the need for 40 or 60 treatments. If the concussed patient can get hyperbaric treatment immediately, then they will likely only need a handful of treatments. If you do this, HBOT treatments can be very affordable since the patient can return to their base line very quickly; eliminating the need to sit in a dark room and rest the brain, or deal with the migraines and dreaded post-concussive syndrome that typically follows a bad concussion. Like everything in the medical field, the treatment in Hyperbaric Oxygen Therapy is no different.

Early intervention is key.

 

Guests

Elena Schertz, NP

Elena Schertz, NP - Clinic Manager at Extivita RTP

Elena attained her Bachelors of Science in Nursing from Michigan State University and received her Masters of Science in Nursing from Simmons University in Boston, MA. She has been practicing integrative medicine since 2010 and is currently working on her certification in functional medicine from the Institute of Functional Medicine.

Elena worked as a nurse in the pediatric oncology, cardiac, and surgical units at UNC hospitals for 15 years before deciding to work in integrative medicine. After years of working as a nurse, she decided to pursue her graduate degree, completing her masters with honors. She is board certified as a Family Nurse Practitioner (FNP) through the American Nurses Credentialing Center.

Elena’s passion for integrative medicine comes from her knowledge that the mind, body and psych/social/spiritual systems are not separate. The focus of Elena’s practice is to approach each of her patient’s healing process from the perspective of the whole, supported and grounded in safety and evidence-based medicine. She also maintains close consultative relationships with experts in the field to promote and enhance wellness for her patients. Elena joined the wonderful Extivita team in March 2019 and is thrilled to be a part of advancing health and wellness through hyperbaric medicine.

 

Elena Schertz, NP

Thomas M. Fox, MAS,MS, CHT - Safety Director at Extivita RTP

Tom is the Research Physiologist for the Hyperbaric Institute for Research and Training, a division of Island Hyperbaric Centre in Pincourt QC. He has worked in the field of Clinical Hyperbaric Oxygen for the last 30 years. During this time, he has been intimately involved with the implementation and the development of the US Army’s Clinical Hyperbaric Service at Dwight David Eisenhower Army Medical Center. He has provided contract hyperbaric services since 1997. Prior to accepting his current position in Quebec, Canada, Mr. Fox served as the Chief of the Atmospherics Branch of the U.S. Army School of Aviation Medicine, Fort Rucker Alabama. In this capacity, he was responsible for hyperbaric/ hypobaric operations and training of US and NATO aviators, flight surgeons and flight medics. Mr. Fox is a senior army aviator and flew twelve years as a Medical Evacuation Pilot for the US Army.

Tom joined the Extivita team in 2022 as the Safety Director, helping Extivita to maintain a healthy and safe environment for exceptional patient care.

 

Extivita-RTP – Hyperbaric Oxygen Therapy Clinic

2012-D TW Alexander Drive
Durham, NC 27709
919-354-3775
919-354-3776
contact@extivita.org
https://www.extivita.org/

Subscribe Now, It’s Free!

[contact-form-7 id="65934" title="Subscribe"]

Recent HBOT News

Clinical Trial – HBOT Late Radiation Tissue Injury

Background: Radiotherapy is a common treatment for many malignancies. Radiation-related
complications developing months or years after radiation treatment are known as late
radiation tissue injury (LRTI) and are estimated to effect 5%-15% of all long-term survivors
who have received radiation.

Hyperbaric oxygen therapy (HBOT) is a well established treatment of LRTI. Most of the studies
evaluating effect of HBOT on LRTI are focused on survival, resolution of tissue damage and
improvement in LENT-SOMA scale. Very few studies have addressed effect of HBOT on pain in
LTRI. Krahn and colleagues were the first to report the analgesic effect of HBOT in 3 cases
of refractory pain in oncological patients with radiation soft tissue injury. Other studies
showed significant improvement in pain intensity in patients with breast cancer and pelvic
malignancies treated with HBOT for LTRI. In patients that had developed radiation- induced
brachial plexopathy, HBOT elicited an increase in warm pain thresholds and a reduction in
lymphoedema. A prospective case study of 16 patients with gynecological cancer found no
changes with respect to pain and depression outcomes. A trial in patients with radiation
induced proctopathy showed that 75% of patients with rectal pain had some improvement,
although none experienced a complete resolution of pain symptoms.

There are several mechanisms by which HBOT may elicit analgesic effects. There is a growing
body of evidence that HBOT’s analgesic effect related to nitric oxide metabolism and
endogenous opioid secretion. Furthermore, the inhibition of tumor necrosis factor alph
(TNF-α), the production of substance P, and the modulation of serotonergic pathways have all
demonstrated a modification in the pain response following HBOT. In animal studies HBOT
decreased allodynia and hyperalgesia in different models of neuropathic and inflammatory
pain. The long lasting antinociceptive effect of HBOT was found to be dose-dependent in
non-injured tissues.

In human studies, HBOT decreased pain and edema and improved function in patients suffering
from the complex regional pain syndrome, and improved pain scores and range of motion in
patients with idiopathic femoral head necrosis. Women suffering from interstitial cystitis
demonstrated a reduction in pelvic pain following weeks and months of HBOT treatment. In
patients suffering from idiopathic trigeminal neuralgia HBOT produced a rapid reduction in
symptoms and these effects were lasting for 6 months following treatment. HBOT was also found
to be an effective treatment for cluster headaches and migraines and alleviated muscle and
bone pains in patients with myofascial syndrome, fibromyalgia, and biphosphonate-related
osteonecrosis of the jaw.

Based on the evidence presented above and HBOT’s known analgesic effect in many conditions,
the investigators designed this study with the objective to evaluate if HBOT reduces pain,
improves depression and impacts on patients quality of life in patients suffering from late
radiation tissue injury.

Study Design: Prospective observational study (n=300). Patients that have had radiation
therapy for malignancy, developed late radiation injury and suffer from chronic pain.

Clinical Trial – HBOT in Fibromyalgia

Fibromyalgia (FM) is a chronic pain condition affecting several millions of Canadians.
Although the etiology and pathophysiology are poorly understood, there is a well-recognized
association between muscular pain in fibromyalgia and muscular hypoperfusion, hypoxia,
abnormal muscle metabolism and oxidative stress. Currently there is no cure for FM.
Pharmacological and non-pharmacological strategies are directed to control symptoms such as
pain, fatigue, non-restorative sleep and depression.

Hyperbaric oxygen therapy (HBOT) is an intermittent inhalation of 100% oxygen in a hyperbaric
chamber at a pressure higher than 1 absolute atmosphere. Physiological effect of HBOT is
based on a dramatic increase in the amount of dissolved oxygen carried by the blood which
enables oxygenation of ischemic areas with compromised circulation. It also activates
oxidant-antioxidant system, stimulates angio- and neurogenesis, modulates inflammatory
response, induces brain neuroplasticity and possesses analgesic effect.

While some interventions offer benefit for some patients, additional treatment alternatives
are needed for patients with FM in whom currently available options are either ineffective or
poorly tolerated. Given its physiological effect, HBOT could be considered as a potential
therapy for treatment of underlying muscular hypoxia, optimizing oxidant- antioxidant system
and controlling FM symptoms. The results from this study could therefore provide new
information supporting the basic science underling the pathophysiology of this disease and
stimulate novel therapies for patients suffering with FM.